BioXcel Therapeutics Inc
(STU:BX2)
€
0.4469
-0.0927 (-17.18%)
Market Cap: 18.50 Mil
Enterprise Value: 84.72 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 16/100 BioXcel Therapeutics Inc at Jefferies Healthcare Conference Transcript
Jun 08, 2023 / 06:30PM GMT
Release Date Price:
€18.71
(-3.66%)
Chris Howerton
(Trades, Portfolio) LLC - Moderator
Okay. I think we're about to get started here. Thank you, everybody, for joining us. My name is Chris Howerton, part of the Jefferies biotechnology research team.
Really excited to be seeing everybody here at our conference. And then, of course, to be hosting a fireside chat with BioXcel. So thanks for joining us, gentlemen. Vimal and the team are here with us. So thank you so much.
Okay. So maybe, Vimal, I'll start off with you. If you could maybe just start off and maybe give us a bit of an overview or an elevator pitch of the company.
Vimal Mehta
BioXcel Therapeutics, Inc. - CEO
Happy to do that.
First of all, thank you for hosting us here and for the fireside chat. And good
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot